Media Pack
News

Current Edition

Volume 6 Issue 3

Upcoming Events

Advertisement

 
 
Cell Therapy: Challenges and Perspectives
Volume 2 Issue 4

Cell Therapy: Challenges and Perspectives

The achievements of cell-based therapeutics over the last decades have bolstered efforts in recent years to bring more of these products to market and across an ever ...
3 February 2020 Volume 2 Issue 4
Continue Reading →
Modelling Cancer for Immuno-oncology Applications: Past, Present & Future
Volume 2 Issue 4

Modelling Cancer for Immuno-oncology Applications: Past, Present & Future

Cancer therapeutics have come a long way in a short time span, leading to significant paradigm shifts in drug discovery. The emergence of checkpoint inhibitors that t...
3 February 2020 Volume 2 Issue 4
Continue Reading →
Is Liver Biopsy a Gold or an Old Standard in NAFL and NASH?
Volume 2 Issue 4

Is Liver Biopsy a Gold or an Old Standard in NAFL and NASH?

When defining the term gold standard, the most appropriate definition is “a benchmark test that is the best available under reasonable conditions”. Rafal Ziecina at W...
3 February 2020 Volume 2 Issue 4
Continue Reading →
Split Butterfly Valve Technology and Eradicating the Risk of Contamination in Biologics Manufacturing
Volume 2 Issue 4

Split Butterfly Valve Technology and Eradicating the Risk of Contamination in Biologics Manufacturing

As new biological therapies continue to be developed, the market has seen an increased need for innovation. Demand  has grown for improved operational efficiency and ...
3 February 2020 Volume 2 Issue 4
Continue Reading →
Meeting the Standards Required for Effective Biorepository Management
Volume 2 Issue 4

Meeting the Standards Required for Effective Biorepository Management

Biorepositories are a key asset for many organisations including those in the biotechnology, pharmaceutical and medical research areas. As they may contain human tiss...
3 February 2020 Volume 2 Issue 4
Continue Reading →
Is the Absence of Data Integrity Software Affecting the Assurance of Gel Clot Assays in Bacterial Endotoxin Testing?
Volume 2 Issue 4

Is the Absence of Data Integrity Software Affecting the Assurance of Gel Clot Assays in Bacterial Endotoxin Testing?

Data integrity remains an important topic in pharmaceutical and biopharmaceutical manufacturing science. The purpose of data integrity is to ensure that the accurate ...
3 February 2020 Volume 2 Issue 4
Continue Reading →
Best Practices of IoT Implementation for Smart Drug Research
Volume 2 Issue 4

Best Practices of IoT Implementation for Smart Drug Research

Drug discovery takes years to complete. Testing a single compound can cost more than £1.5 billion. Experiments on animals often fail to predict human behaviours and r...
3 February 2020 Volume 2 Issue 4
Continue Reading →
Managing Global Supply Chains
Volume 2 Issue 4

Managing Global Supply Chains

As temperature-sensitive pharmaceutical products are increasingly being shipped globally to more remote regions, there is an even greater demand for the effective and...
3 February 2020 Volume 2 Issue 4
Continue Reading →
 
 
 
 
 
IBI-white.png

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Facebook Linkedin
Bio Pharmaceutical Media © 2023, All Rights Reserved – Powered by Teksyte